OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 49 citing articles:

Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications
Yang Qiu-rong, Jing Xu, Jianmei Gu, et al.
Advanced Science (2022) Vol. 9, Iss. 34
Open Access | Times Cited: 81

The role of microRNAs in the gastric cancer tumor microenvironment
Xianzhe Yu, Yin Zhang, Fengming Luo, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 16

Role of exosomal miRNAs and macrophage polarization in gastric cancer: a novel therapeutic strategy
Yun Zhang, Baozhen Wang, Jing Chen, et al.
European Journal of Pharmacology (2025), pp. 177268-177268
Closed Access | Times Cited: 2

HMGA2 regulation by miRNAs in cancer: Affecting cancer hallmarks and therapy response
Mehrdad Hashemi, Mohsen Rashidi, Kiavash Hushmandi, et al.
Pharmacological Research (2023) Vol. 190, pp. 106732-106732
Open Access | Times Cited: 24

Exosomal microRNAs in regulation of tumor cells resistance to apoptosis
Mohammad Salehi, Mohammad Javad Kamali, Daniyal Arab, et al.
Biochemistry and Biophysics Reports (2024) Vol. 37, pp. 101644-101644
Open Access | Times Cited: 15

Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancers
Yuan Li, Silei Sui, Ajay Goel
Seminars in Cancer Biology (2024) Vol. 99, pp. 5-23
Closed Access | Times Cited: 12

Exosome inhibition improves response to first‐line therapy in small cell lung cancer
Nesrin Irep, Kubilay İnci, Pervin Elvan Tokgün, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 9

Tumor-derived small extracellular vesicles: potential roles and mechanism in glioma
Xu Guo, Rui Sui, Haozhe Piao
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 31

Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments
Shiyou Wei, Zhigang Chen, Xinyu Ling, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 22

METTL3 regulates thyroid cancer differentiation and chemosensitivity by modulating PAX8
Kang Ning, Zewei Zhao, Zhongyu Wang, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 9, pp. 3426-3441
Open Access | Times Cited: 6

Exosomes: Diagnostic and Therapeutic Implications in Cancer
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1465-1465
Open Access | Times Cited: 16

A state-of-art of underlying molecular mechanisms and pharmacological interventions/nanotherapeutics for cisplatin resistance in gastric cancer
Jitendra Gupta, Abdulrahman T. Ahmed, Nahla A. Tayyib, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115337-115337
Open Access | Times Cited: 15

Circulating Exosome Cargoes Contain Functionally Diverse Cancer Biomarkers: From Biogenesis and Function to Purification and Potential Translational Utility
Megan I. Mitchell, Junfeng Ma, Claire L. Carter, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3350-3350
Open Access | Times Cited: 19

Mechanism of cisplatin resistance in gastric cancer and associated microRNAs
Changqing Liu, Shan Li, Yunlian Tang
Cancer Chemotherapy and Pharmacology (2023) Vol. 92, Iss. 5, pp. 329-340
Closed Access | Times Cited: 12

Non-coding RNAs’ function in cancer development, diagnosis and therapy
Xinyi Zhang, Xiaoqing Xu, Jiajia Song, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115527-115527
Open Access | Times Cited: 11

Exosomes as a drug delivery tool for cancer therapy: a new era for existing drugs and oncolytic viruses
Yoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 807-816
Closed Access | Times Cited: 11

Cancer‐derived non‐coding RNAs endow tumor microenvironment with immunosuppressive properties
Tong Hu, Run Shi, Yunru Gu, et al.
Wiley Interdisciplinary Reviews - RNA (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Non-coding RNA and drug resistance in head and neck cancer
Yulong Zhang, Yingming Peng, Bingqin Lin, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 4

Low miR-224-5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4
Yanyan Yan, Zhuo-fen Deng, Xueying Wu, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101211-101211
Closed Access

Exosomes play a crucial role in remodeling the tumor microenvironment and in the treatment of gastric cancer
Lingyun Tang, Wenjie Zhang, Teng Fei Qi, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access

USP2 reversed cisplatin resistance through p53-mediated ferroptosis in NSCLC
Yanmei Gong, Ruichao Li, Rui Zhang, et al.
BMC Medical Genomics (2025) Vol. 18, Iss. 1
Open Access

Extracellular vesicles: messengers of cross-talk between gastric cancer cells and the tumor microenvironment
Xiwen Li, Xian Lu, Mi Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Extracellular transfer of HuR promotes acquired cisplatin resistance in esophageal cancer cells
Yayun Cui, Xiaofeng Zhu, Liting Qian, et al.
Cancer Biology & Therapy (2025) Vol. 26, Iss. 1
Open Access

Page 1 - Next Page

Scroll to top